Arkolith/Insider Trading/PTGX/Form 4

Ali Asif

Chief Financial OfficerProtagonist Therapeutics, Inc (PTGX) · full profile →Form 4 · filed Jan 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.8M
Net Open-Market Flow
-$3.8M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2026Option exercise(M)12K$12.17$146K107K
Jan 27, 2026Option exercise(M)16K$19.19$307K95K
Jan 27, 2026Sell(S)28K$83.13$2.3M79K
Jan 27, 2026Sell(S)18K$83.14$1.5M60K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 27, 2026Option exercise(M)16K—$051K
Jan 27, 2026Option exercise(M)12K—$019K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-007128) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML